Ondansetron HCL 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7PLB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,998
Award facts
- Contract value 100% obligated
- $1,998.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Ondansetron HCL 4 mg tablets (30-count) with a ceiling value of $1,998.10.
Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 13, 2026, and is priced on a firm fixed-price basis with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26F7PLB?
SPE2DR26F7PLB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 12, 2026.
How much is contract SPE2DR26F7PLB worth?
The government has obligated $1,998 on SPE2DR26F7PLB.
Is contract SPE2DR26F7PLB an order under another contract?
Yes. SPE2DR26F7PLB is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7PLB competed?
The extent of competition for SPE2DR26F7PLB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award